secwatch.observer — SEC 8-K summary
======================================

Issuer:     DYADIC INTERNATIONAL INC (DYAI)
CIK:        0001213809
Form:       8-K
Filed at:   2024-03-11T23:59:59+00:00
Accession:  0001437749-24-007270
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dyadic closes $6M convertible note financing with insider participation to fund commercialization
--------------------------------------------------------------------------------

- $6M aggregate principal, 8% senior secured convertible notes, due March 2027, conversion at $1.79/share.
- Purchasers include CEO Mark Emalfarb's family members and The Francisco Trust (>5% holder).
- Net proceeds of ~$5.85M after expenses; intended for working capital and corporate purposes.
- Funds to accelerate C1 and Dapibus platform commercialization after positive Phase I clinical results.
- Registration rights agreement filed for shares underlying the convertible notes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1213809/000143774924007270/0001437749-24-007270-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1213809/000143774924007270/dyai20240308_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-007270

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer